News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,421 Results
Type
Article (41690)
Company Profile (464)
Press Release (659267)
Section
Business (208489)
Career Advice (2011)
Deals (35972)
Drug Delivery (92)
Drug Development (83334)
Employer Resources (169)
FDA (16345)
Job Trends (15050)
News (352320)
Policy (33060)
Tag
Academia (2622)
Alliances (50619)
Alzheimer's disease (1273)
Approvals (16268)
Artificial intelligence (137)
Bankruptcy (361)
Best Places to Work (11737)
Biotechnology (349)
Breast cancer (121)
Cancer (1097)
Cardiovascular disease (102)
Career advice (1679)
Cell therapy (246)
Clinical research (65987)
Collaboration (396)
Compensation (195)
COVID-19 (2591)
C-suite (97)
Data (1116)
Diabetes (156)
Diagnostics (6197)
Earnings (86071)
Employer resources (147)
Events (112920)
Executive appointments (302)
FDA (16872)
Funding (354)
Gene therapy (191)
GLP-1 (610)
Government (4415)
Healthcare (18999)
Infectious disease (2674)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16584)
Job creations (3696)
Job search strategy (1434)
Layoffs (439)
Legal (7939)
Lung cancer (172)
Manufacturing (178)
Medical device (13332)
Medtech (13337)
Mergers & acquisitions (19441)
Metabolic disorders (421)
Neuroscience (1555)
NextGen Class of 2024 (6738)
Non-profit (4535)
Northern California (1473)
Obesity (241)
Opinion (197)
Patents (101)
People (57625)
Phase I (20667)
Phase II (29127)
Phase III (21550)
Pipeline (455)
Postmarket research (2593)
Preclinical (8874)
Radiopharmaceuticals (251)
Rare diseases (231)
Real estate (6000)
Regulatory (22010)
Research institute (2404)
Resumes & cover letters (354)
Southern California (1306)
Startups (3747)
United States (13668)
Vaccines (568)
Weight loss (182)
Date
Today (156)
Last 7 days (988)
Last 30 days (3810)
Last 365 days (36669)
2024 (33423)
2023 (41038)
2022 (52320)
2021 (56801)
2020 (54953)
2019 (47461)
2018 (35718)
2017 (33044)
2016 (32366)
2015 (38427)
2014 (32204)
2013 (27143)
2012 (29252)
2011 (29896)
2010 (28017)
Location
Africa (734)
Arizona (200)
Asia (38538)
Australia (6406)
California (3363)
Canada (1281)
China (248)
Colorado (146)
Connecticut (155)
Europe (84119)
Florida (448)
Georgia (116)
Illinois (351)
Indiana (196)
Kansas (99)
Maryland (588)
Massachusetts (2692)
Michigan (155)
Minnesota (275)
New Jersey (953)
New York (953)
North Carolina (753)
Northern California (1473)
Ohio (137)
Pennsylvania (843)
South America (1107)
Southern California (1306)
Texas (463)
Utah (92)
Washington State (368)
701,421 Results for "revision therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Deals
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”) (Nasdaq: VNDA) today confirmed that it has received a revised unsolicited proposal from Future Pak, LLC (“Future Pak”) to acquire the Company.
May 7, 2024
·
1 min read
Pharm Country
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis.
May 20, 2024
·
5 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Business
Avanos Medical, Inc. Reports Preliminary Fourth Quarter and Full-Year 2023 Financial Results; Revises Preliminary 2024 Revenue Outlook
Avanos Medical, Inc. reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024.
January 4, 2024
·
6 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
October 25, 2024
·
4 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
1 of 70,143
Next
